Results of the VIVA trial show that a program of three screening tests–for abdominal aortic aneurysm, peripheral arterial disease, and hypertension–resulted in a significant reduction in all-cause mortality at 5 years.
Source: ‘Triple’ Screening for AAA, PAD, High BP Reduces Mortality